Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer (NCT07100288) | Clinical Trial Compass
RecruitingNot Applicable
Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer
Spain200 participantsStarted 2025-07-20
Plain-language summary
Involvement of the infundibulopelvic ligament in ovarian cancer may be associated with decreased survival and related to paraaortic lymph node metastasis
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* â—¦ Patients with epithelial ovarian cancer, including high- and low-grade serous, high- and low-grade endometrioid, mucinous (expansile and infiltrative types), and carcinosarcoma.
* FIGO 2014 stage IA-IVB.
* Patients undergoing primary surgery or interval surgery after 3-4 or 6 cycles of chemtherapy
* Patients with no residual disease after surgery.
* Patients with ECOG performance status 0-1.
Exclusion Criteria:
* â—¦ Patients without epithelial ovarian cancer.
* Patients with ECOG 2-4.
* Patients who do not consent to participate in the study.
* Patients who did not undergo complete staging surgery (including hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and omentectomy) or with residual disease after cytoreductive surgery.
What they're measuring
1
metastasis in infundibulopelvic ligament
Timeframe: Through study completion, an average of 5 year